4.6 Article

Regression of Lung Cancer in Mice by Intranasal Administration of SARS-CoV-2 Spike S1

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model

Tianyun Qiao et al.

Summary: Antibodies targeting the PD-1/PD-L1 pathway have changed the treatment landscape of NSCLC, but combination therapy is needed. This study found that combining immunotherapy with anti-angiogenic therapy has a synergistic effect in local tumor control and neoadjuvant therapy, providing a theoretical basis for clinical applications.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2023)

Article Oncology

Changes in survival of patients with non-small cell lung cancer in Japan: An interrupted time series study

Yukari Taniyama et al.

Summary: Introduction of EGFR-TKIs and EGFR mutation testing has led to improved survival in NSCLC patients, particularly in women with adenocarcinoma and at advanced stages.

CANCER SCIENCE (2023)

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Cell Biology

Regression of Triple-Negative Breast Cancer in a Patient-Derived Xenograft Mouse Model by Monoclonal Antibodies against IL-12 p40 Monomer

Madhuchhanda Kundu et al.

Summary: The study revealed that neutralization of p40 protein can induce cell death in human TNBC cells and tumor shrinkage in PDX mice. Further neutralization of p40 led to upregulation of human immune cell subtypes, while simultaneously decreasing levels of certain immune factors.
Article Oncology

Non-Small-Cell Lung Cancer in 2022: A Review for General Practitioners in Oncology

Hamid Mithoowani et al.

Summary: This article presents a comprehensive review of the current best practices in the treatment of non-small cell lung cancer in Canada, covering screening, management of early stage and locally-advanced disease, as well as management of patients with metastatic disease. It also focuses on the incorporation of immunotherapy into practice and its associated toxicities.

CURRENT ONCOLOGY (2022)

Review Neurosciences

Is COVID-19 Gender-sensitive?

Shreya Mukherjee et al.

Summary: Sex differences in ACE2 receptor and TMPRSS2 expression, as well as immunological responses, may explain the disparities in COVID-19 severity and fatality between males and females. Behaviors such as smoking and comorbidities may also contribute to gendered differences in clinical outcomes of COVID-19 infections. An understanding of these sex and gender sensitivities is crucial for the development of effective treatments and therapies for the virus.

JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2021)

Article Neurosciences

ACE-2-interacting Domain of SARS-CoV-2 (AIDS) Peptide Suppresses Inflammation to Reduce Fever and Protect Lungs and Heart in Mice: Implications for COVID-19 Therapy

Ramesh K. Paidi et al.

Summary: Research has shown that designing an AIDS peptide to interfere with the binding of SARS-CoV-2 to ACE2 can inhibit viral activity in lung cells and have a protective effect on COVID-19 symptoms.

JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2021)

Article Immunology

Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses

Ramesh K. Paidi et al.

Summary: The designed SPIDAR can inhibit the inflammatory response by interfering with the interaction between SARS-CoV-2 and ACE2 receptor, which protects the lungs and is beneficial in combating the coronavirus.

JOURNAL OF IMMUNOLOGY (2021)

Article Neurosciences

Eugenol, a Component of Holy Basil (Tulsi) and Common Spice Clove, Inhibits the Interaction Between SARS-CoV-2 Spike S1 and ACE2 to Induce Therapeutic Responses

Ramesh Kumar Paidi et al.

Summary: Eugenol found in holy basil inhibits the interaction between SARS-CoV-2 spike S1 protein and ACE2 receptor, preventing the virus from entering host cells. Other major components of holy basil, such as ursolic acid and oleanolic acid, do not show the same inhibitory effect as eugenol.

JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2021)

Article Neurosciences

Upregulation of IL-1 Receptor Antagonist by Aspirin in Glial Cells via Peroxisome Proliferator-Activated Receptor-Alpha

Sudipta Chakrabarti et al.

Summary: Aspirin upregulates IL-1Ra in the brain by binding to PPAR alpha and stimulating its activity, therefore reducing inflammation in different neurological conditions.

JOURNAL OF ALZHEIMERS DISEASE REPORTS (2021)

Article Oncology

Prenatal stress enhances NNK-induced lung tumors in A/J mice

Tomoaki Ito et al.

CARCINOGENESIS (2020)

Review Neurosciences

Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?

Priyanka Pahan et al.

JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2020)

Letter Medicine, General & Internal

COVID-19: consider cytokine storm syndromes and immunosuppression

Puja Mehta et al.

LANCET (2020)

Article Medicine, Research & Experimental

Upregulation of BDNF and hippocampal functions by a hippocampal ligand of PPARα

Dhruv Patel et al.

JCI INSIGHT (2020)

Review Neurosciences

The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections

Jatin Machhi et al.

JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2020)

Article Multidisciplinary Sciences

IL-12 p40 monomer is different from other IL-12 family members to selectively inhibit IL-12Rβ1 internalization and suppress EAE

Susanta Mondal et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Review Respiratory System

Update 2020: Management of Non-Small Cell Lung Cancer

Mariam Alexander et al.

Article Multidisciplinary Sciences

Selective neutralization of IL-12 p40 monomer induces death in prostate cancer cells via IL-12-IFN-γ

Madhuchhanda Kundu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Review Biochemistry & Molecular Biology

Cytokines in immunogenic cell death: Applications for cancer immunotherapy

Anne Showalter et al.

CYTOKINE (2017)

Review Respiratory System

Immunotherapy for lung cancer

Antonius Steven et al.

RESPIROLOGY (2016)

Review Oncology

Refining the treatment of NSCLC according to histological and molecular subtypes

Anish Thomas et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2015)

Article Medicine, General & Internal

First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer

Benjamin J. Solomon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Review Oncology

Targeting apoptosis pathways in lung cancer

Milind M. Pore et al.

CANCER LETTERS (2013)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Article Respiratory System

Lung Cancer: Epidemiology, Etiology, and Prevention

Charles S. Dela Cruz et al.

CLINICS IN CHEST MEDICINE (2011)

Review Microbiology

The spike protein of SARS-CoV - a target for vaccine and therapeutic development

Lanying Du et al.

NATURE REVIEWS MICROBIOLOGY (2009)

Review Biotechnology & Applied Microbiology

Drugs targeting the renin-angiotensin-aldosterone system

MA Zaman et al.

NATURE REVIEWS DRUG DISCOVERY (2002)

Article Biochemistry & Molecular Biology

BAD Ser-155 phosphorylation regulates BAD/Bcl-XL interaction and cell survival

Y Tan et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2000)

Review Biochemistry & Molecular Biology

The hallmarks of cancer

D Hanahan et al.